On this episode of Fortune’s Leadership Next podcast, host Diane Brady talks to Eli Lilly chair and CEO Dave Ricks. They ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

BioCrossroads has named Eli Lilly CEO, Dave Ricks, the recipient of the 2024 August M. Watanabe Life Sciences Champion of the ...

The president-elect is expected to lean of tariffs to influence trade, loosen government regulations on companies and try to lower corporate taxes. Pete weighs in on potential winners and losers.

Conditions are getting a bit more challenging for the drugmaker.

Year-over-year BioSpace data shows there are fewer job postings live on the website and far more competition for them.

Industrial SalesLeads released its October 2024 report on planned capital project spending in the Industrial Manufacturing ...

Ladies and gentlemen, thank you for standing-by, and welcome to the Lilly Q3 2024 Earnings Call. [Operator Instructions] I ...

Teva Pharmaceuticals is being fined $503 million (€463 million) by the European Commission for delaying competition posed by ...

Eli Lilly on Wednesday fell short of profit and revenue expectations for the third quarter, weighed down by disappointing sales of its blockbuster weight loss drug Zepbound and diabetes treatment ...